Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Thursday, with changes in price targets for multiple companies. Morgan Stanley cut the price target for ArcBest Corporation (ARCB) from $136 to $125. Truist Securities increased the price target for Owens Corning (OC) from $105 to $135. Goldman Sachs increased the price target for Netflix, Inc. (NFLX) from $230 to $400. Cantor Fitzgerald cut Regeneron Pharmaceuticals, Inc. (REGN) price target from $815 to $795. JMP Securities boosted Protagonist Therapeutics, Inc. (PTGX) price target from $28 to $35. Raymond James slashed Comerica Incorporated (CMA) price target from $57 to $53. Rosenblatt raised CME Group Inc. (CME) price target from $161 to $169. B of A Securities raised the price target for BorgWarner Inc. (BWA) from $54 to $67. Keybanc boosted Meta Platforms, Inc. (META) price target from $280 to $335. Jefferies increased Amedisys, Inc. (AMED) price target from $98 to $101. Citigroup raised D.R. Horton, Inc. (DHI) price target from $124 to $140.
July 06, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies increased Amedisys, Inc. price target from $98 to $101.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
B of A Securities raised the price target for BorgWarner Inc. from $54 to $67.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Rosenblatt raised CME Group Inc. price target from $161 to $169.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Citigroup raised D.R. Horton, Inc. price target from $124 to $140.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Keybanc boosted Meta Platforms, Inc. price target from $280 to $335.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Goldman Sachs increased the price target for Netflix, Inc. from $230 to $400.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Truist Securities increased the price target for Owens Corning from $105 to $135.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
JMP Securities boosted Protagonist Therapeutics, Inc. price target from $28 to $35.
The increase in price target by a major analyst could lead to a positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Morgan Stanley cut the price target for ArcBest Corporation from $136 to $125.
The reduction in price target by a major analyst could lead to a negative sentiment among investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Raymond James slashed Comerica Incorporated price target from $57 to $53.
The reduction in price target by a major analyst could lead to a negative sentiment among investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Cantor Fitzgerald cut Regeneron Pharmaceuticals, Inc. price target from $815 to $795.
The reduction in price target by a major analyst could lead to a negative sentiment among investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100